Literature DB >> 620304

Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

G Ninane, J Joly, M Kraytman.   

Abstract

Transtracheal punctures were performed in 193 miners of anthracosilicotic coal who presented with an acute exacerbation of chronic bronchitis. The transtracheal aspirates were bacteriologically positive in 104 patients. Branhamella catarrhalis was isolated in 15 patients; 10 of these responded to chemotherapy, as shown by the resolution of all symptoms and the disappearance of the organism on a repeat transtracheal puncture performed 48 hours after the end of treatment. One ampicillin-treated patient, whose bronchial secretions yielded a beta-lactamase-producing B catarrhalis, showed no improvement. But subsequent treatment with cefuroxime was followed by clinical and bacteriological recovery. B catarrhalis probably acted as an opportunistic respiratory pathogen in these patients, who were probably compromised hosts in view of their clinical history. B catarrhalis normally responds to the penicillins commonly used for respiratory infections, but if treatment fails a transtracheal puncture is essential to identify the strain and determine an appropriate antibiotic.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620304      PMCID: PMC1602712          DOI: 10.1136/bmj.1.6108.276

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  A COMPARISON OF TRANSTRACHEAL ASPIRATION WITH OTHER METHODS OF DETERMINING THE BACTERIAL FLORA OF THE LOWER RESPIRATORY TRACT.

Authors:  D V PECORA
Journal:  N Engl J Med       Date:  1963-09-26       Impact factor: 91.245

2.  Use of transtracheal aspiration in the bacteriological diagnosis of bronchopulmonary infections.

Authors:  E Schoutens; J P De Koster; J Vereerstraeten; M Tombroff; E Yourassowsky
Journal:  Biomedicine       Date:  1973-04-10

3.  Transtracheal aspiration in the diagnosis of lower respiratory tract infections.

Authors:  A Schreiner; A Digranes; O Myking
Journal:  Scand J Infect Dis       Date:  1972

4.  Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae.

Authors:  R B Sykes; A Griffiths; D M Ryan
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

5.  Cefuroxime - a new cephalosporin antibiotic.

Authors:  C H O'Callaghan; R B Sykes; D M Ryan; R D Foord; P W Muggleton
Journal:  J Antibiot (Tokyo)       Date:  1976-01       Impact factor: 2.649

Review 6.  Role of infection in chronic bronchitis.

Authors:  I Tager; F E Speizer
Journal:  N Engl J Med       Date:  1975-03-13       Impact factor: 91.245

7.  Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host.

Authors:  D J McNeely; C S Kitchens; R M Kluge
Journal:  Am Rev Respir Dis       Date:  1976-08

8.  Branhamella (Neisseria) catarrhalis as pathogen.

Authors:  G Ninane; J Joly; P Piot; M Kraytman
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

9.  In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis.

Authors:  B E Malmvall; J E Brorsson; J Johnsson
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

10.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

View more
  45 in total

1.  Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia.

Authors:  C DiGiovanni; T V Riley; G F Hoyne; R Yeo; P Cooksey
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

2.  Characterisation of Branhamella catarrhalis and differentiation from Neisseria species in a diagnostic laboratory.

Authors:  F Ahmad; H Young; D T McLeod; M J Croughan; M A Calder
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

3.  Branhamella catarrhalis in lower respiratory tract secretions in adults.

Authors:  H Schønheyder; T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

Review 4.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

5.  Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.

Authors:  P E Thornley; J M Aitken; G M Nichol; N J Slevin
Journal:  Drugs       Date:  1986       Impact factor: 9.546

6.  Branhamella keratitis.

Authors:  K R Wilhelmus; J Peacock; D J Coster
Journal:  Br J Ophthalmol       Date:  1980-12       Impact factor: 4.638

7.  Isolation of Branhamella catarrhalis from sputum and tracheal aspirate.

Authors:  J M Aitken; P E Thornley
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

8.  Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response.

Authors:  D T McLeod; F Ahmad; M J Croughan; M A Calder
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Branhamella catarrhalis respiratory infections in The Netherlands.

Authors:  F P Maesen; B I Davies
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Branhamella catarrhalis as an indirect pathogen.

Authors:  J K Wardle
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.